nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—migraine—Prednisone—chronic obstructive pulmonary disease	0.59	1	CpDpCtD
Metoclopramide—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.108	0.478	CbGbCtD
Metoclopramide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0406	0.18	CbGbCtD
Metoclopramide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0406	0.18	CbGbCtD
Metoclopramide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0362	0.161	CbGbCtD
Metoclopramide—Cardio-respiratory arrest—Aminophylline—chronic obstructive pulmonary disease	0.00344	0.0318	CcSEcCtD
Metoclopramide—Completed suicide—Roflumilast—chronic obstructive pulmonary disease	0.00313	0.029	CcSEcCtD
Metoclopramide—Suicidal ideation—Roflumilast—chronic obstructive pulmonary disease	0.00262	0.0243	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00187	0.0173	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.0164	CcSEcCtD
Metoclopramide—Suicide—Montelukast—chronic obstructive pulmonary disease	0.00176	0.0163	CcSEcCtD
Metoclopramide—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.0152	CcSEcCtD
Metoclopramide—Block heart—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.0152	CcSEcCtD
Metoclopramide—Block heart—Formoterol—chronic obstructive pulmonary disease	0.00165	0.0152	CcSEcCtD
Metoclopramide—Completed suicide—Montelukast—chronic obstructive pulmonary disease	0.00156	0.0144	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00143	0.0132	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.0132	CcSEcCtD
Metoclopramide—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.0131	CcSEcCtD
Metoclopramide—Supraventricular tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.0125	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.0107	CcSEcCtD
Metoclopramide—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0095	CcSEcCtD
Metoclopramide—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.000963	0.00891	CcSEcCtD
Metoclopramide—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.000963	0.00891	CcSEcCtD
Metoclopramide—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.00094	0.0087	CcSEcCtD
Metoclopramide—Amisulpride—HTR2A—chronic obstructive pulmonary disease	0.000925	0.433	CrCbGaD
Metoclopramide—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.000914	0.00846	CcSEcCtD
Metoclopramide—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.000889	0.00823	CcSEcCtD
Metoclopramide—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.000857	0.00793	CcSEcCtD
Metoclopramide—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000781	0.00723	CcSEcCtD
Metoclopramide—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000774	0.00716	CcSEcCtD
Metoclopramide—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.00698	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.000748	0.00692	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.000748	0.00692	CcSEcCtD
Metoclopramide—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000735	0.00681	CcSEcCtD
Metoclopramide—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.000716	0.00662	CcSEcCtD
Metoclopramide—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.000716	0.00662	CcSEcCtD
Metoclopramide—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000711	0.00658	CcSEcCtD
Metoclopramide—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000683	0.00632	CcSEcCtD
Metoclopramide—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.000676	0.00625	CcSEcCtD
Metoclopramide—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.000664	0.00615	CcSEcCtD
Metoclopramide—Cisapride—CYP1A2—chronic obstructive pulmonary disease	0.000657	0.307	CrCbGaD
Metoclopramide—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000594	0.0055	CcSEcCtD
Metoclopramide—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000586	0.00543	CcSEcCtD
Metoclopramide—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000586	0.00543	CcSEcCtD
Metoclopramide—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000576	0.00534	CcSEcCtD
Metoclopramide—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000576	0.00534	CcSEcCtD
Metoclopramide—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000574	0.00531	CcSEcCtD
Metoclopramide—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000572	0.0053	CcSEcCtD
Metoclopramide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000566	0.00524	CcSEcCtD
Metoclopramide—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00056	0.00519	CcSEcCtD
Metoclopramide—Cisapride—HTR2A—chronic obstructive pulmonary disease	0.000554	0.259	CrCbGaD
Metoclopramide—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.00512	CcSEcCtD
Metoclopramide—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.00504	CcSEcCtD
Metoclopramide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000541	0.00501	CcSEcCtD
Metoclopramide—Suicidal ideation—Prednisone—chronic obstructive pulmonary disease	0.000524	0.00485	CcSEcCtD
Metoclopramide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000522	0.00483	CcSEcCtD
Metoclopramide—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000521	0.00482	CcSEcCtD
Metoclopramide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00474	CcSEcCtD
Metoclopramide—Mania—Prednisone—chronic obstructive pulmonary disease	0.000505	0.00468	CcSEcCtD
Metoclopramide—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00465	CcSEcCtD
Metoclopramide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00462	CcSEcCtD
Metoclopramide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00457	CcSEcCtD
Metoclopramide—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.00456	CcSEcCtD
Metoclopramide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000484	0.00448	CcSEcCtD
Metoclopramide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00445	CcSEcCtD
Metoclopramide—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.00048	0.00445	CcSEcCtD
Metoclopramide—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000474	0.00439	CcSEcCtD
Metoclopramide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000471	0.00436	CcSEcCtD
Metoclopramide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000465	0.0043	CcSEcCtD
Metoclopramide—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000462	0.00428	CcSEcCtD
Metoclopramide—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000457	0.00423	CcSEcCtD
Metoclopramide—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000455	0.00421	CcSEcCtD
Metoclopramide—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00418	CcSEcCtD
Metoclopramide—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00418	CcSEcCtD
Metoclopramide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000449	0.00416	CcSEcCtD
Metoclopramide—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00414	CcSEcCtD
Metoclopramide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000437	0.00404	CcSEcCtD
Metoclopramide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000434	0.00402	CcSEcCtD
Metoclopramide—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00396	CcSEcCtD
Metoclopramide—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000427	0.00396	CcSEcCtD
Metoclopramide—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000418	0.00387	CcSEcCtD
Metoclopramide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000414	0.00383	CcSEcCtD
Metoclopramide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000414	0.00383	CcSEcCtD
Metoclopramide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.00382	CcSEcCtD
Metoclopramide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000411	0.00381	CcSEcCtD
Metoclopramide—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00381	CcSEcCtD
Metoclopramide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000409	0.00379	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00375	CcSEcCtD
Metoclopramide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00373	CcSEcCtD
Metoclopramide—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00367	CcSEcCtD
Metoclopramide—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00367	CcSEcCtD
Metoclopramide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000396	0.00367	CcSEcCtD
Metoclopramide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00363	CcSEcCtD
Metoclopramide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00363	CcSEcCtD
Metoclopramide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00039	0.00361	CcSEcCtD
Metoclopramide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.00359	CcSEcCtD
Metoclopramide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00356	CcSEcCtD
Metoclopramide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00354	CcSEcCtD
Metoclopramide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00354	CcSEcCtD
Metoclopramide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00347	CcSEcCtD
Metoclopramide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00347	CcSEcCtD
Metoclopramide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00347	CcSEcCtD
Metoclopramide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00347	CcSEcCtD
Metoclopramide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000374	0.00346	CcSEcCtD
Metoclopramide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00345	CcSEcCtD
Metoclopramide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00345	CcSEcCtD
Metoclopramide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00343	CcSEcCtD
Metoclopramide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000368	0.0034	CcSEcCtD
Metoclopramide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00338	CcSEcCtD
Metoclopramide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00334	CcSEcCtD
Metoclopramide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00334	CcSEcCtD
Metoclopramide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00334	CcSEcCtD
Metoclopramide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00328	CcSEcCtD
Metoclopramide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00327	CcSEcCtD
Metoclopramide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00326	CcSEcCtD
Metoclopramide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00326	CcSEcCtD
Metoclopramide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00326	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00323	CcSEcCtD
Metoclopramide—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00323	CcSEcCtD
Metoclopramide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.00322	CcSEcCtD
Metoclopramide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00321	CcSEcCtD
Metoclopramide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00321	CcSEcCtD
Metoclopramide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00321	CcSEcCtD
Metoclopramide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000346	0.0032	CcSEcCtD
Metoclopramide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00315	CcSEcCtD
Metoclopramide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00314	CcSEcCtD
Metoclopramide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00309	CcSEcCtD
Metoclopramide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00309	CcSEcCtD
Metoclopramide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.00308	CcSEcCtD
Metoclopramide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000328	0.00304	CcSEcCtD
Metoclopramide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00303	CcSEcCtD
Metoclopramide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00302	CcSEcCtD
Metoclopramide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00301	CcSEcCtD
Metoclopramide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00301	CcSEcCtD
Metoclopramide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00299	CcSEcCtD
Metoclopramide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00291	CcSEcCtD
Metoclopramide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00288	CcSEcCtD
Metoclopramide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00288	CcSEcCtD
Metoclopramide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00284	CcSEcCtD
Metoclopramide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000304	0.00282	CcSEcCtD
Metoclopramide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00279	CcSEcCtD
Metoclopramide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00279	CcSEcCtD
Metoclopramide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.00277	CcSEcCtD
Metoclopramide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00275	CcSEcCtD
Metoclopramide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00275	CcSEcCtD
Metoclopramide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00274	CcSEcCtD
Metoclopramide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00274	CcSEcCtD
Metoclopramide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000295	0.00273	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00272	CcSEcCtD
Metoclopramide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00272	CcSEcCtD
Metoclopramide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00269	CcSEcCtD
Metoclopramide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.00268	CcSEcCtD
Metoclopramide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00266	CcSEcCtD
Metoclopramide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00266	CcSEcCtD
Metoclopramide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00263	CcSEcCtD
Metoclopramide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00261	CcSEcCtD
Metoclopramide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.0026	CcSEcCtD
Metoclopramide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00259	CcSEcCtD
Metoclopramide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.00256	CcSEcCtD
Metoclopramide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.00255	CcSEcCtD
Metoclopramide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00254	CcSEcCtD
Metoclopramide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00254	CcSEcCtD
Metoclopramide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.00254	CcSEcCtD
Metoclopramide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00253	CcSEcCtD
Metoclopramide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00251	CcSEcCtD
Metoclopramide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00245	CcSEcCtD
Metoclopramide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00245	CcSEcCtD
Metoclopramide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00244	CcSEcCtD
Metoclopramide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00244	CcSEcCtD
Metoclopramide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00241	CcSEcCtD
Metoclopramide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00241	CcSEcCtD
Metoclopramide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00241	CcSEcCtD
Metoclopramide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000259	0.0024	CcSEcCtD
Metoclopramide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.0024	CcSEcCtD
Metoclopramide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00239	CcSEcCtD
Metoclopramide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00239	CcSEcCtD
Metoclopramide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00239	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00235	CcSEcCtD
Metoclopramide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00231	CcSEcCtD
Metoclopramide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.0023	CcSEcCtD
Metoclopramide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00227	CcSEcCtD
Metoclopramide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00227	CcSEcCtD
Metoclopramide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00227	CcSEcCtD
Metoclopramide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00227	CcSEcCtD
Metoclopramide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00223	CcSEcCtD
Metoclopramide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00221	CcSEcCtD
Metoclopramide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00221	CcSEcCtD
Metoclopramide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00217	CcSEcCtD
Metoclopramide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00215	CcSEcCtD
Metoclopramide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00211	CcSEcCtD
Metoclopramide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00211	CcSEcCtD
Metoclopramide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00209	CcSEcCtD
Metoclopramide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00207	CcSEcCtD
Metoclopramide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00204	CcSEcCtD
Metoclopramide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00204	CcSEcCtD
Metoclopramide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000216	0.002	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000216	0.002	CcSEcCtD
Metoclopramide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00199	CcSEcCtD
Metoclopramide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00197	CcSEcCtD
Metoclopramide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00195	CcSEcCtD
Metoclopramide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00195	CcSEcCtD
Metoclopramide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00194	CcSEcCtD
Metoclopramide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00194	CcSEcCtD
Metoclopramide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00193	CcSEcCtD
Metoclopramide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00193	CcSEcCtD
Metoclopramide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00193	CcSEcCtD
Metoclopramide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00191	CcSEcCtD
Metoclopramide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000206	0.0019	CcSEcCtD
Metoclopramide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000205	0.0019	CcSEcCtD
Metoclopramide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00189	CcSEcCtD
Metoclopramide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00187	CcSEcCtD
Metoclopramide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00184	CcSEcCtD
Metoclopramide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00184	CcSEcCtD
Metoclopramide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00183	CcSEcCtD
Metoclopramide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00183	CcSEcCtD
Metoclopramide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00182	CcSEcCtD
Metoclopramide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00179	CcSEcCtD
Metoclopramide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.00177	CcSEcCtD
Metoclopramide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00177	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00174	CcSEcCtD
Metoclopramide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00173	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000184	0.0017	CcSEcCtD
Metoclopramide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00167	CcSEcCtD
Metoclopramide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00163	CcSEcCtD
Metoclopramide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00159	CcSEcCtD
Metoclopramide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00151	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00138	CcSEcCtD
Metoclopramide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00137	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00136	CcSEcCtD
Metoclopramide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00133	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00129	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00128	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00126	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00123	CcSEcCtD
Metoclopramide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00121	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00118	CcSEcCtD
Metoclopramide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.0011	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.0011	CcSEcCtD
Metoclopramide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00105	CcSEcCtD
Metoclopramide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00105	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00105	CcSEcCtD
Metoclopramide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00105	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000108	0.001	CcSEcCtD
Metoclopramide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000992	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000965	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00096	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000894	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.41e-05	0.000871	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.29e-05	0.00124	CbGpPWpGaD
Metoclopramide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.18e-05	0.00123	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.05e-05	0.00121	CbGpPWpGaD
Metoclopramide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.97e-05	0.000831	CcSEcCtD
Metoclopramide—CYP17A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.69e-05	0.00116	CbGpPWpGaD
Metoclopramide—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.67e-05	0.000803	CcSEcCtD
Metoclopramide—HTR4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.65e-05	0.00116	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.59e-05	0.00115	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.51e-05	0.00114	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	8.37e-05	0.00112	CbGpPWpGaD
Metoclopramide—Rash—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000766	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000765	CcSEcCtD
Metoclopramide—Headache—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000761	CcSEcCtD
Metoclopramide—CHRM1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	8.17e-05	0.00109	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.15e-05	0.00109	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.14e-05	0.00109	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	8.08e-05	0.00108	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.08e-05	0.00108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.04e-05	0.00108	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.99e-05	0.00107	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	7.8e-05	0.00104	CbGpPWpGaD
Metoclopramide—Nausea—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000721	CcSEcCtD
Metoclopramide—HTR4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.73e-05	0.00103	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.67e-05	0.00103	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	7.51e-05	0.001	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.45e-05	0.000996	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.41e-05	0.000991	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	7.38e-05	0.000987	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	7.35e-05	0.000983	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	7.31e-05	0.000977	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	7.22e-05	0.000966	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	7.22e-05	0.000966	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	7.15e-05	0.000956	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	7.07e-05	0.000945	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.93e-05	0.000927	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.88e-05	0.00092	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.76e-05	0.000905	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.71e-05	0.000898	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.62e-05	0.000886	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	6.57e-05	0.000879	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	6.41e-05	0.000857	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	6.39e-05	0.000855	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.34e-05	0.000848	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.32e-05	0.000845	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	6.27e-05	0.000839	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.26e-05	0.000838	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.25e-05	0.000836	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.19e-05	0.000828	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.16e-05	0.000824	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.15e-05	0.000823	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.05e-05	0.00081	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.02e-05	0.000805	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	5.97e-05	0.000799	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.96e-05	0.000797	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	5.84e-05	0.000782	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.84e-05	0.000781	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.72e-05	0.000765	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.64e-05	0.000755	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.6e-05	0.000749	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.55e-05	0.000742	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.54e-05	0.000741	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.53e-05	0.000739	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.52e-05	0.000739	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.52e-05	0.000739	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.5e-05	0.000736	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.46e-05	0.000731	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.44e-05	0.000727	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5.41e-05	0.000724	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.4e-05	0.000722	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.27e-05	0.000705	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.26e-05	0.000704	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.15e-05	0.000689	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.15e-05	0.000688	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.11e-05	0.000684	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.11e-05	0.000683	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.08e-05	0.000679	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.05e-05	0.000676	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.04e-05	0.000674	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.03e-05	0.000673	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.03e-05	0.000673	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.93e-05	0.000659	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	4.92e-05	0.000658	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.91e-05	0.000657	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.88e-05	0.000653	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.87e-05	0.000651	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.84e-05	0.000647	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.81e-05	0.000644	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.81e-05	0.000644	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.78e-05	0.00064	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.73e-05	0.000633	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.71e-05	0.00063	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.71e-05	0.00063	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.68e-05	0.000626	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.61e-05	0.000617	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.61e-05	0.000616	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.6e-05	0.000616	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.57e-05	0.000611	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.54e-05	0.000607	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.39e-05	0.000588	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.33e-05	0.00058	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.25e-05	0.000568	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.24e-05	0.000568	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.21e-05	0.000563	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.18e-05	0.000559	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.15e-05	0.000556	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.15e-05	0.000555	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.12e-05	0.000551	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.04e-05	0.00054	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4e-05	0.000534	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.92e-05	0.000525	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.9e-05	0.000522	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.87e-05	0.000518	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.85e-05	0.000516	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.83e-05	0.000512	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.79e-05	0.000506	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.77e-05	0.000505	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.76e-05	0.000503	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.73e-05	0.000499	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.73e-05	0.000499	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.71e-05	0.000497	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.69e-05	0.000494	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.68e-05	0.000493	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.65e-05	0.000488	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.6e-05	0.000482	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.54e-05	0.000474	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.49e-05	0.000467	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.48e-05	0.000465	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.48e-05	0.000465	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.41e-05	0.000457	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.3e-05	0.000441	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.25e-05	0.000435	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.16e-05	0.000423	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.13e-05	0.000418	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.11e-05	0.000416	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.08e-05	0.000413	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.05e-05	0.000409	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.99e-05	0.0004	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.98e-05	0.000398	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.97e-05	0.000398	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.92e-05	0.000391	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.91e-05	0.00039	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000386	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.82e-05	0.000378	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.82e-05	0.000378	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.78e-05	0.000372	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.76e-05	0.00037	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.72e-05	0.000364	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.66e-05	0.000356	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.61e-05	0.00035	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.61e-05	0.000349	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ALB—chronic obstructive pulmonary disease	2.6e-05	0.000348	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.6e-05	0.000348	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.56e-05	0.000342	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.53e-05	0.000338	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.49e-05	0.000333	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.47e-05	0.00033	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.47e-05	0.00033	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.42e-05	0.000323	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.39e-05	0.00032	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.38e-05	0.000318	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.37e-05	0.000316	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.35e-05	0.000315	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.35e-05	0.000314	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.34e-05	0.000313	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.33e-05	0.000311	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.28e-05	0.000305	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.28e-05	0.000304	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALB—chronic obstructive pulmonary disease	2.24e-05	0.0003	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.23e-05	0.000299	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.23e-05	0.000298	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.23e-05	0.000298	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000297	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.18e-05	0.000291	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.16e-05	0.000289	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.14e-05	0.000287	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.11e-05	0.000283	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.1e-05	0.000281	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.08e-05	0.000278	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.04e-05	0.000272	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.02e-05	0.000271	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.01e-05	0.000268	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2e-05	0.000268	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.89e-05	0.000253	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.87e-05	0.00025	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.85e-05	0.000247	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.84e-05	0.000246	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.8e-05	0.000241	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.68e-05	0.000225	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.67e-05	0.000223	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.66e-05	0.000223	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.63e-05	0.000218	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.55e-05	0.000207	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.53e-05	0.000204	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.52e-05	0.000203	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.51e-05	0.000203	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.51e-05	0.000203	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.46e-05	0.000195	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.43e-05	0.000191	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.4e-05	0.000187	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.39e-05	0.000185	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.38e-05	0.000185	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.37e-05	0.000183	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.36e-05	0.000181	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.000172	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.28e-05	0.000171	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.000168	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.25e-05	0.000167	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000167	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000156	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.16e-05	0.000155	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.000154	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.000153	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.14e-05	0.000152	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.12e-05	0.000149	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.12e-05	0.000149	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.000146	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.06e-05	0.000142	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.04e-05	0.000139	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000136	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.02e-05	0.000136	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.58e-06	0.000128	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.44e-06	0.000126	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.01e-06	0.000121	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.8e-06	0.000118	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.57e-06	0.000115	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.53e-06	0.000114	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.35e-06	0.000112	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.34e-06	0.000112	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.15e-06	0.000109	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.14e-06	0.000109	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.97e-06	0.000107	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.78e-06	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.61e-06	0.000102	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.32e-06	9.79e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.9e-06	9.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.75e-06	9.03e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.72e-06	8.99e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.59e-06	8.81e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.56e-06	8.77e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.42e-06	8.59e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.24e-06	8.35e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.11e-06	8.17e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.67e-06	7.59e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.6e-06	7.49e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.53e-06	7.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.48e-06	7.33e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.42e-06	7.26e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.14e-06	6.88e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.06e-06	6.77e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.04e-06	6.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.03e-06	6.73e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.93e-06	6.6e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.23e-06	5.66e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.14e-06	5.54e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.87e-06	5.18e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.79e-06	5.07e-05	CbGpPWpGaD
